Skip to main content

Month: July 2024

Sify Q1 Earnings Call deferred due to outage on vendor platform

CHENNAI, India, July 19, 2024 (GLOBE NEWSWIRE) — Sify Technologies Limited (NASDAQ: SIFY), India’s leading Digital ICT solutions provider, today announced that that due to technical issues on the teleconference vendor platform, the earning call slated for July 19, 2024 at 8.30 AM ET (today) could not be conducted. The company regrets the inconvenience caused but the circumstances were entirely beyond the company’s control. The company further assures investors that it will announce a new date for the earning call at the earliest as soon as these issues are sorted. About Sify Technologies A Fortune India 500 company, Sify Technologies is India’s most comprehensive ICT service & solution provider. With Cloud at the core of our solutions portfolio, Sify is focussed on the changing ICT requirements of the emerging Digital economy...

Continue reading

Reliance Global Group Schedules Second Quarter 2024 Financial Results and Business Update Conference Call

Lakewood, NJ, July 19, 2024 (GLOBE NEWSWIRE) — Reliance Global Group, Inc. (NASDAQ: RELI) (“Reliance” or the “Company”), announced today that it will host a conference call Thursday, July 25, 2024, at 4:30 PM Eastern Time to discuss financial results for the second quarter of 2024 and provide a business update. The conference call will be available via telephone by dialing toll-free +1 888-506-0062 for U.S. callers or +1 973-528-0011 for international callers and entering access code 246542. A webcast of the call may be accessed at https://www.webcaster4.com/Webcast/Page/2381/50932 or on the investor relations section of the Company’s website, https://relianceglobalgroup.com/events-and-presentations/. A webcast replay will be available on the investor relations section of the Company’s website at https://relianceglobalgroup.com/events-and-presentations/...

Continue reading

Statkraft AS: Release of second quarter results 2024

Statkraft discloses second quarter results for 2024 on Tuesday 23 July 2024 at 08:00 a.m. CEST. Material will be available on Statkraft’s website www.statkraft.com and Oslo Stock Exchange’s news service www.newsweb.no. Webcast09:30 a.m. CEST: Statkraft presents the results in a webcast at www.statkraft.com. The presentation will be held in English. Contact:Arild Ratikainen, Investor Contact, tlf.: +47 971 74 132, e-mail: arild.ratikainen@statkraft.com

Continue reading

BCB Bancorp, Inc. Earns $2.8 Million in Second Quarter 2024; Reports $0.14 EPS and Declares Quarterly Cash Dividend of $0.16 Per Share

BAYONNE, N.J., July 19, 2024 (GLOBE NEWSWIRE) — BCB Bancorp, Inc. (the “Company”), (NASDAQ: BCBP), the holding company for BCB Community Bank (the “Bank”), today reported net income of $2.8 million for the second quarter of 2024, compared to $5.9 million in the first quarter of 2024, and $8.6 million for the second quarter of 2023. Earnings per diluted share for the second quarter of 2024 were $0.14, compared to $0.32 in the preceding quarter and $0.50 in the second quarter of 2023. During the second quarter, the Bank agreed to sell a pool of its commercial real estate and multifamily loans with a total balance of $38.4 million as of June 30, 2024. The Bank expects to consummate the loan sale during the third quarter. As a result, the Bank recorded a pre-tax loss of $4.6 million as the loans were moved to held for sale from the...

Continue reading

Nokia accelerates its share buybacks

Nokia CorporationStock Exchange Release19 July 2024 at 16:00 EEST Nokia accelerates its share buybacks Espoo, Finland – Nokia Corporation (“Nokia” or the “Company”) has on 18 March 2024 announced the first phase of its share buyback program and, in line with the announcement made on 18 July 2024, has today decided to accelerate its share buybacks by increasing the number of shares to be repurchased during the year 2024. The main terms of the ongoing phase of the share buyback program post-increase:The aggregate purchase price of all Nokia shares to be acquired shall not exceed EUR 600 million (an increase from the initially announced EUR 300 million). As repurchases for an aggregate purchase price of approximately EUR 132 million have already been executed in 2024, the aggregate purchase price for shares to be...

Continue reading

UPDATE — Logansport Financial Corp. Reports Net Earnings for the Quarter Ended June 30, 2024

LOGANSPORT, Ind., July 19, 2024 (GLOBE NEWSWIRE) — Logansport Financial Corp., (OTCQB, LOGN), parent company of Logansport Savings Bank, reported net earnings for the quarter ended June 30, 2024 of $349,000 or $0.57 per diluted share, compared to earnings in 2023 of $529,000 or $0.86 per diluted share. Year to date the company reported net earnings of $617,000 for 2024 compared to $1,127,000 for 2023. Diluted earnings per share for the six months ended June 30, 2024 were $1.01 compared to $1.84 for the six months ended June 30, 2023. Total assets at June 30, 2024 were $249.6 million compared to total assets at June 30, 2023 of $253.2 million. Total Deposits at June 30, 2024 were $211.7 million compared to total deposits of $216.2 million at June 30, 2023. The company paid a total of $0.90 per share in dividends in the first half...

Continue reading

Sports Medicine Market to Surpass USD 12.04 Billion by 2031, Witnessing 5.6% CAGR Growth | SkyQuest Technology

Westford, USA, July 19, 2024 (GLOBE NEWSWIRE) — SkyQuest projects that the Sports Medicine Market will attain a value of USD 12.04 billion by 2031, with a CAGR of 5.6% over the forecast period (2024-2031). Performance of an athlete is of paramount importance for any sport and sports medicine improves just that. Rapidly increasing demand for better sports medicine and growing spending of athletes on different products to enhance their performance contributes to high demand for sports medicine. Growing investments in sports medicine and R&D will also bolster market growth in the future.  Download a detailed overview:https://www.skyquestt.com/sample-request/sports-medicine-market Browse in-depth TOC on “Sports Medicine Market” Pages – 165 Tables – 100 Figures – 78Sports Medicine Market Overview:Report...

Continue reading

Ackroo Releases Q2 2024 Financial Results

Ackroo delivers 113% YoY EBITDA growth representing 32% of total revenues HAMILTON, Ontario, July 19, 2024 (GLOBE NEWSWIRE) — Ackroo Inc. (TSX-V: AKR; OTC: AKRFF) (the “Company”), a gift card, loyalty marketing, payments and point-of-sale technology consolidator and services provider, has filed its financial results for the period ended June 30, 2024. The Company is pleased to report quarterly revenues of $1,633,238 which includes $1,461,199 of recurring subscription revenue. The results represent a 1% increase in total revenue and a 4% increase in recurring revenue over the same period in 2023. The Company also achieved $515,635 of adjusted EBITDA* during the period totaling 32% of total revenues representing a 113% increase over the same period in 2023. The Company is very pleased with the continued EBITDA growth and the many...

Continue reading

60 Degrees Pharmaceuticals Signs Clinical Trial Agreements With All Planned Trial Sites for Tafenoquine Babesiosis Study

The Tafenoquine for Babesiosis clinical trial will be conducted at three sites: Yale University, Rhode Island Hospital and Tufts Medical Center Patient enrollment has begun; interim results anticipated by September, 2025 In the Northeast U.S., the incidence of babesiosis has been increasing; babesiosis is an emerging, tick-borne, potentially life-threatening illness Case studies in recent medical literature suggest that tafenoquine combined with standard-of-care treatment exhibits a high cure rate in immunosuppressed patients who have relapsing babesiosis and for whom prior treatment has failed Total cumulative accessible market through the end of patent protection in the U.S. for ARAKODA® (tafenoquine) for babesiosis is approximately 400,000 patientsWASHINGTON, July 19, 2024 (GLOBE NEWSWIRE) — 60 Degrees Pharmaceuticals, Inc....

Continue reading

Sify (NASDAQ: SIFY) reports Consolidated Financial Results for Q1 FY 2024-25

Revenues of INR 9,421 Million. EBITDA of INR 1,784 Million. Loss for the period INR 105 Million. CHENNAI, India, July 19, 2024 (GLOBE NEWSWIRE) — EARNING CALLS DETAILS                                                   July 19, 2024| 8:30 AM ET Participant Dial in: To join: +1-888-506-0062 (Toll Free in the U.S. or Canada) or +1-973-528-0011 (International) | Access Code: 265815 On the call: Mr. Raju Vegesna, Chairman of the Board, Mr. M P Vijay Kumar, Executive Director & Group CFO and Mr. Kamal Nath, Chief Executive Officer Live webcast: https://www.webcaster4.com/Webcast/Page/2184/50888 Archives: +1-877-481-4010 (Toll Free in the U.S. or Canada) or +1-919-882-2331 (International). On prompt, please enter passcode 50888. Replay is available until July 26, 2024. ————————————————————————————— HIGHLIGHTSRevenue...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.